SSS International Clinical Research GmBH   Report issue

For profit Phase 2
Founded: Germering Germany (2007)

Organization Overview

First Clinical Trial
2020
NCT04195373
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

SSS International Clinical Research GmbH | SSS International Medical Research GmbH

Active Ingredients

Drugs in Phase 2 Trials (3)

Fluorocytosine (1 trial)

nivolumab (opdivo) (1 trial)

tmv-018 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gastrointestinal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3